The Food and Drug Administration is phasing out certain asthma inhalers as part of a multi-nation agreement to stop using substances that deplete the Earth's ozone layer. Patients who use epinephrine inhalers to treat mild asthma have a few months to switch to a prescription-only alternative. Find out when the phased-out inhalers will no longer be sold.
No comments:
Post a Comment